Biora Therapeutics (BIOR) PT Raised to $6 at H.C. Wainwright

July 14, 2022 12:05 PM EDT Send to a Friend
H.C. Wainwright analyst Joseph Pantginis raised the price target on Biora Therapeutics (NASDAQ: BIOR) to $6.00 (from $4.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login